Evidence mapPaperPMID 37445988Full record

SynthesisInternational journal of molecular sciences2023

Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.

Martín Salamini-Montemurri, Mónica Lamas-Maceiras, Lidia Lorenzo-Catoira, Ángel Vizoso-Vázquez, Aida Barreiro-Alonso, Esther Rodríguez-Belmonte, María Quindós-Varela, M Esperanza Cerdán

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. LncRNAJournal of biomedical research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Martín Salamini-MontemurriCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0002-0149-5493
Mónica Lamas-MaceirasCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-8025-2838
Lidia Lorenzo-CatoiraCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.
Ángel Vizoso-VázquezCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-7310-2102
Aida Barreiro-AlonsoCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.
Esther Rodríguez-BelmonteCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-8243-1303
María Quindós-VarelaInstituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
M Esperanza CerdánCentro Interdisciplinar de Química e Bioloxía (CICA), As Carballeiras, s/n, Campus de Elviña, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-8540-1417
Universidade da Coruña · ESComplexo Hospitalario Universitario A Coruña · ES

Funding

Instituto de Salud Carlos III PI18/01417Ministerio de Ciencia e Innovación. Spain PID2021-124564OB-I00Ministerio de Ciencia Innovación y Universidades SPAIN Predoctoral fellowshipr to M.S-M.The European Regional Development Fund-ERDF "A way of Making Europe" cofinancer: PI18/01417; PID2021-124564OB-I00; ED431C 2020-08Xunta de Galicia ED431C 2020-08
6 · The paper itself

Abstract

Epithelial ovarian cancer (EOC) is one of the deadliest gynecological cancers worldwide, mainly because of its initially asymptomatic nature and consequently late diagnosis. Long non-coding RNAs (lncRNA) are non-coding transcripts of more than 200 nucleotides, whose deregulation is involved in pathologies such as EOC, and are therefore envisaged as future biomarkers. We present a meta-analysis of available gene expression profiling (microarray and RNA sequencing) studies from EOC patients to identify lncRNA genes with diagnostic and prognostic value. In this meta-analysis, we include 46 independent cohorts, along with available expression profiling data from EOC cell lines. Differential expression analyses were conducted to identify those lncRNAs that are deregulated in (i) EOC versus healthy ovary tissue, (ii) unfavorable versus more favorable prognosis, (iii) metastatic versus primary tumors, (iv) chemoresistant versus chemosensitive EOC, and (v) correlation to specific histological subtypes of EOC. From the results of this meta-analysis, we established a panel of lncRNAs that are highly correlated with EOC. The panel includes several lncRNAs that are already known and even functionally characterized in EOC, but also lncRNAs that have not been previously correlated with this cancer, and which are discussed in relation to their putative role in EOC and their potential use as clinically relevant tools.

Indexed as

Ovarian NeoplasmsRNA, Long NoncodingBiomarkers, TumorCarcinoma, Ovarian EpithelialCell Line, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansBiomarkers, TumorRNA, Long Noncodingepithelial ovarian cancer (EOC)long non-coding RNAs (lncRNAs)meta-analysistranscriptomics

Identifiers

PMID37445988
PMCPMC10341812
OpenAlexW4382724808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.